Cystatin M / E expression in inflammatory and neoplastic skin disorders

Area of Science:

• Dermatology and Molecular Biology
• Proteinase Inhibition
• Skin Physiology

Background:

• Cystatins are natural inhibitors of cysteine proteinases, crucial for regulating proteolysis in various diseases.
• Cystatin M/E, a novel cystatin family member, is uniquely expressed in the skin, with unknown physiological functions.
• Imbalances between proteinases and inhibitors contribute to skin damage in inflammation and tumor invasion.

Purpose of the Study:

• To investigate cystatin M/E expression in inflammatory and neoplastic skin conditions.
• To elucidate the potential function of cystatin M/E in skin pathology.
• To determine if cystatin M/E expression can differentiate between various skin neoplasias.

Main Methods:

• Immunohistochemical detection of cystatin M/E using specific antibodies.
• Analysis of biopsy samples from normal skin, atopic dermatitis, psoriasis, wound healing, and various epidermal neoplasms.
• Comparison with squamous neoplasias of non-cutaneous origin.

Main Results:

• Cystatin M/E is constitutively expressed in normal skin appendages and the stratum granulosum.
• Expression extends to the stratum spinosum in inflammatory conditions (atopic dermatitis, psoriasis).
• In epidermal neoplasms, cystatin M/E is restricted to differentiated cells and keratinized nests.

Conclusions:

• Inflammation induces cystatin M/E expression in spinous layers, potentially co-localizing with transglutaminase.
• Increased cystatin M/E expression may play a role in controlling cysteine proteinases during inflammation and infection.
• Cystatin M/E expression in neoplastic epidermis is confined to well-differentiated cells, lacking discriminatory power between benign and (pre)malignant lesions.